在卵巢癌中的血管内皮生成因子通路
Yuxin Zhao1, Qiaochu Chen1, Jia Li2
1Heilongjiang University of Chinese Medicine, Harbin, China.
Journal of ovarian research
|November 19, 2025
概括
血管内皮生长因子 (VEGF) 驱动卵巢癌的进展,入侵和化学抵抗. 向VEGF提供了一个有希望的策略,以改善治疗结果,并延长这种致命恶性瘤患者的存活时间.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌是最致命的妇科恶性瘤,大多数患者在晚期被诊断出来.
- 目前的手术和化疗等治疗方法只能提供暂时的控制,复发和抗药性是常见的.
- 血管内皮生长因子 (VEGF) 在卵巢癌的瘤生长,扩散和治疗耐药性方面发挥着关键作用.
研究的目的:
- 综合当前关于血管内皮生长因子 (VEGF) 在卵巢癌中的信号传导的知识.
- 在瘤微环境中识别VEGF的上游调节器和下游途径.
- 对卵巢癌的VEGF向疗法进行审查.
主要方法:
- 关于卵巢癌中VEGF信号的现有研究的文献综合.
- 对VEGF表达的上游调节者的分析.
- 影响VEGF的下游路径的划定.
- 对VEGF向药物的临床数据的审查.
主要成果:
- 在卵巢癌中,VEGF促进新血管生成,侵袭,转移和化学抵抗.
- VEGF信号传递与恶性炎的形成有关.
- 针对VEGF的疗法旨在重新设计瘤血管,以恢复药物敏感性.
结论:
- 在卵巢癌的进展和治疗耐药性方面,VEGF是核心参与者.
- 通过分子疗法和免疫疗法准VEGF是一种合理的策略,可以克服治疗的局限性.
- 以VEGF为导向的方法对精准医学具有前景,可能改善患者的生存率并延长治疗效益.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K


